CompletedPhase 4

Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia

United States20 participantsStarted 2021-10-19

Plain-language summary

Study of Ingrezza (Valbenazine) for the treatment of cervical dystonia.

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. According to the C-SSRS, he or she must not be actively suicidal at Visit 1 (Screening) or Visit 2 (Baseline) (including, an answer of "yes" to C-SSRS questions 4 or 5 \[current or over the last 6 months\]) and must not have attempted suicide in the 1 year prior to Visit 1 (Screening); OR
✕. The subject is actively suicidal in the Investigator's judgment

Change in incidence of pain/spasm

Timeframe: 16 weeks

NCT IDNCT05157100

SponsorThe Orthopedic Foundation

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-15